Presentation is loading. Please wait.

Presentation is loading. Please wait.

Risk factors for atherosclerosis and the degeneration of pericardial valves after aortic valve replacement  Georg Nollert, MD, Jessica Miksch, MD, Eckart.

Published byAubrie Hubbard Modified over 5 years ago

Similar presentations

Presentation on theme: "Risk factors for atherosclerosis and the degeneration of pericardial valves after aortic valve replacement  Georg Nollert, MD, Jessica Miksch, MD, Eckart."— Presentation transcript:

1 Risk factors for atherosclerosis and the degeneration of pericardial valves after aortic valve replacement  Georg Nollert, MD, Jessica Miksch, MD, Eckart Kreuzer, MD, Bruno Reichart, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 126, Issue 4, Pages (October 2003) DOI: /S (02)

2 Figure 1 Reoperation rate according to preoperative characteristics in younger patients (<57 years). Degeneration of the Hancock pericardial aortic bioprosthesis leading to reoperation is substantially influenced by sex (a), smoking habits (b), diabetes mellitus (c), cholesterol levels (d), and triglyceride levels (e). Indication for surgical intervention had no effect on reoperation (f). OP, Operation; Chol, cholesterol; Trig, triglyceride; AR, aortic regurgitation; AS, aortic stenosis. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /S (02) )

Download ppt "Risk factors for atherosclerosis and the degeneration of pericardial valves after aortic valve replacement  Georg Nollert, MD, Jessica Miksch, MD, Eckart."

Similar presentations

Tubular heart valves: A new tissue prosthesis design—Preclinical evaluation of the 3F aortic bioprosthesis James L. Cox, MD, Niv Ad, MD, Keith Myers, BS,

Tubular heart valves: A new tissue prosthesis design—Preclinical evaluation of the 3F aortic bioprosthesis James L. Cox, MD, Niv Ad, MD, Keith Myers, BS,
Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: Summary assessment of.

Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: Summary assessment of.
Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 

Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 
Of mice and men and surgical transcatheter aortic valve insertion

Of mice and men and surgical transcatheter aortic valve insertion
Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters  Victor Dayan, MD, PhD, Philippe Pibarot,

Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters  Victor Dayan, MD, PhD, Philippe Pibarot,
Can papillary muscle interventions improve mitral valve repair durability for ischemic mitral regurgitation?  Christos G. Mihos, DO, Orlando Santana,

Can papillary muscle interventions improve mitral valve repair durability for ischemic mitral regurgitation?  Christos G. Mihos, DO, Orlando Santana,
First successful transapical aortic valve implantation after aortic allograft replacement  Michael Schmoeckel, MD, Peter Boekstegers, MD, Konstantin Nikolaou,

First successful transapical aortic valve implantation after aortic allograft replacement  Michael Schmoeckel, MD, Peter Boekstegers, MD, Konstantin Nikolaou,
Reoperative minimal access aortic valve surgery: Minimal mediastinal dissection and minimal injury risk  Minoru Tabata, MD, MPH, Zain Khalpey, MD, PhD,

Reoperative minimal access aortic valve surgery: Minimal mediastinal dissection and minimal injury risk  Minoru Tabata, MD, MPH, Zain Khalpey, MD, PhD,
Rounding numbers The Journal of Thoracic and Cardiovascular Surgery

Rounding numbers The Journal of Thoracic and Cardiovascular Surgery
Sergey Leontyev, MD, Michael A

Sergey Leontyev, MD, Michael A
In which patients is transcatheter aortic valve replacement potentially better indicated than surgery for redo aortic valve disease? Long-term results.

In which patients is transcatheter aortic valve replacement potentially better indicated than surgery for redo aortic valve disease? Long-term results.
Hancock II Bioprosthesis for Aortic Valve Replacement: The Gold Standard of Bioprosthetic Valves Durability?  Tirone E. David, MD, Susan Armstrong, MS,

Hancock II Bioprosthesis for Aortic Valve Replacement: The Gold Standard of Bioprosthetic Valves Durability?  Tirone E. David, MD, Susan Armstrong, MS,
A new equine pericardial stentless valve

A new equine pericardial stentless valve
Harald C. Eichstaedt, MD, Jerry Easo, MD, Tobias Härle, MD, Otto E

Harald C. Eichstaedt, MD, Jerry Easo, MD, Tobias Härle, MD, Otto E
Long-term results of surgical valvuloplasty for congenital valvar aortic stenosis in children  Claude C Chartrand, MD, Enrique Saro-Servando, MD, Jitka.

Long-term results of surgical valvuloplasty for congenital valvar aortic stenosis in children  Claude C Chartrand, MD, Enrique Saro-Servando, MD, Jitka.
Replacement of the ascending aorta in bicuspid aortic valve disease: Where do we draw the line?  Thoralf M. Sundt, MD  The Journal of Thoracic and Cardiovascular.

Replacement of the ascending aorta in bicuspid aortic valve disease: Where do we draw the line?  Thoralf M. Sundt, MD  The Journal of Thoracic and Cardiovascular.
Minimally invasive transapical aortic valve-in-a-valve implantation for severe aortic regurgitation in a degenerated stentless bioprosthesis  Timotheos.

Minimally invasive transapical aortic valve-in-a-valve implantation for severe aortic regurgitation in a degenerated stentless bioprosthesis  Timotheos.
George J. Reul, M. D. , Denton A. Cooley, M. D. , J. Michael Duncan, M

George J. Reul, M. D. , Denton A. Cooley, M. D. , J. Michael Duncan, M
Long-term follow-up after aortic valve replacement with Edwards Prima Plus stentless bioprostheses in patients younger than 60 years of age  Torsten Christ,

Long-term follow-up after aortic valve replacement with Edwards Prima Plus stentless bioprostheses in patients younger than 60 years of age  Torsten Christ,
Totally percutaneous valve replacement for severe aortic regurgitation in a degenerating bioprosthesis  Massimo Napodano, MD, Ada Cutolo, MD, Chiara Fraccaro,

Totally percutaneous valve replacement for severe aortic regurgitation in a degenerating bioprosthesis  Massimo Napodano, MD, Ada Cutolo, MD, Chiara Fraccaro,

Similar presentations

Ads by Google